Patrick Texereau

4.3k total citations
15 papers, 280 citations indexed

About

Patrick Texereau is a scholar working on Oncology, Pathology and Forensic Medicine and Hepatology. According to data from OpenAlex, Patrick Texereau has authored 15 papers receiving a total of 280 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 5 papers in Pathology and Forensic Medicine and 4 papers in Hepatology. Recurrent topics in Patrick Texereau's work include Colorectal Cancer Treatments and Studies (10 papers), Cancer Treatment and Pharmacology (6 papers) and Genetic factors in colorectal cancer (4 papers). Patrick Texereau is often cited by papers focused on Colorectal Cancer Treatments and Studies (10 papers), Cancer Treatment and Pharmacology (6 papers) and Genetic factors in colorectal cancer (4 papers). Patrick Texereau collaborates with scholars based in France and Belgium. Patrick Texereau's co-authors include Olivier Bouché, Dominique Auby, Michel Ducreux, Marine Castaing, Laurent Bedenne, D. Gargot, Mohamed Gasmi, Jean‐Pierre Pignon, Pierre-Luc Etienne and Moncef Abbas and has published in prestigious journals such as Journal of Clinical Oncology, The Lancet Oncology and Annals of Oncology.

In The Last Decade

Patrick Texereau

15 papers receiving 273 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Patrick Texereau France 8 221 93 81 50 41 15 280
Dong Ma China 5 193 0.9× 78 0.8× 21 0.3× 58 1.2× 53 1.3× 13 284
Catherine Leger France 5 216 1.0× 96 1.0× 28 0.3× 77 1.5× 23 0.6× 10 263
Pierre-Guillaume Poureau France 5 219 1.0× 93 1.0× 27 0.3× 72 1.4× 50 1.2× 12 272
Thomas Göhler Germany 10 132 0.6× 67 0.7× 46 0.6× 28 0.6× 22 0.5× 34 225
Juan José Reina Spain 6 280 1.3× 90 1.0× 79 1.0× 51 1.0× 53 1.3× 8 324
Philip He United States 7 279 1.3× 106 1.1× 270 3.3× 92 1.8× 72 1.8× 22 459
Hendrik Kroening Germany 9 271 1.2× 107 1.2× 64 0.8× 37 0.7× 48 1.2× 21 321
Oxana Crysler United States 7 270 1.2× 62 0.7× 214 2.6× 121 2.4× 65 1.6× 25 432
M. Frueh Switzerland 9 258 1.2× 189 2.0× 40 0.5× 20 0.4× 38 0.9× 31 322
G. Pancera Italy 9 304 1.4× 164 1.8× 30 0.4× 62 1.2× 96 2.3× 19 395

Countries citing papers authored by Patrick Texereau

Since Specialization
Citations

This map shows the geographic impact of Patrick Texereau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick Texereau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick Texereau more than expected).

Fields of papers citing papers by Patrick Texereau

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrick Texereau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick Texereau. The network helps show where Patrick Texereau may publish in the future.

Co-authorship network of co-authors of Patrick Texereau

This figure shows the co-authorship network connecting the top 25 collaborators of Patrick Texereau. A scholar is included among the top collaborators of Patrick Texereau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patrick Texereau. Patrick Texereau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Bachet, Jean‐Baptiste, Déwi Vernerey, Christophe Boisson, et al.. (2024). 532P G-CSF secondary prophylaxis in patients (pts) with metastatic colorectal cancer (mCRC) treated with trifluridine/tipiracil (FTD/TPI): The GERCOR LONGBOARD study. Annals of Oncology. 35. S447–S447. 1 indexed citations
2.
Mosnier, Jean‐François, Julien Masliah‐Planchon, Côme Lepage, et al.. (2020). Loss of SMARCB1 expression in colon carcinoma. Cancer Biomarkers. 27(3). 399–406. 5 indexed citations
3.
Lacas, Benjamin, Olivier Bouché, Pierre-Luc Etienne, et al.. (2019). Quality of life and cost of strategies of two chemotherapy lines in metastatic colorectal cancer: results of the FFCD 2000-05 trial. Expert Review of Pharmacoeconomics & Outcomes Research. 19(5). 601–608. 2 indexed citations
4.
Catena, Vittorio, Y. Bécouarn, Laurent Cany, et al.. (2018). Pulmonary Thermal Ablation Enables Long Chemotherapy-Free Survival in Metastatic Colorectal Cancer Patients. CardioVascular and Interventional Radiology. 41(11). 1727–1734. 25 indexed citations
5.
Aparicio, Thomas, François Ghiringhelli, Valérie Boige, et al.. (2018). Bevacizumab Maintenance Versus No Maintenance During Chemotherapy-Free Intervals in Metastatic Colorectal Cancer: A Randomized Phase III Trial (PRODIGE 9). Journal of Clinical Oncology. 36(7). 674–681. 59 indexed citations
6.
7.
Aparicio, Thomas, Jaafar Bennouna, Karine Le Malicot, et al.. (2016). Final results of PRODIGE 9, a randomized phase III comparing no treatment to bevacizumab maintenance during chemotherapy-free intervals in metastatic colorectal cancer.. Journal of Clinical Oncology. 34(15_suppl). 3531–3531. 7 indexed citations
8.
Bécouarn, Y., Laurent Cany, Marina Pulido, et al.. (2014). FOLFIRI® and Bevacizumab in first-line treatment for colorectal cancer patients: safety, efficacy and genetic polymorphisms. BMC Research Notes. 7(1). 260–260. 17 indexed citations
9.
Michiels, Stefan, Olivier Bouché, Pierre-Luc Etienne, et al.. (2013). Taking into account successive treatment lines in the analysis of a colorectal cancer randomised trial. European Journal of Cancer. 49(8). 1882–1888. 4 indexed citations
10.
Ducreux, Michel, David Malka, Jean Mendiboure, et al.. (2011). Sequential versus combination chemotherapy for the treatment of advanced colorectal cancer (FFCD 2000–05): an open-label, randomised, phase 3 trial. The Lancet Oncology. 12(11). 1032–1044. 114 indexed citations
11.
Bouché, Olivier, Marine Castaing, Pierre Étienne, et al.. (2007). Randomized strategical trial of chemotherapy in metastatic colorectal cancer (FFCD 2000–05): Preliminary results. Journal of Clinical Oncology. 25(18_suppl). 4069–4069. 23 indexed citations
12.
Bécouarn, Y., Anne Rullier, Philippe Gorry, et al.. (2005). Value of microsatellite instability typing in detecting hereditary non-polyposis colorectal cancer. Gastroentérologie Clinique et Biologique. 29(6-7). 667–675. 7 indexed citations
13.
Pariente, A., et al.. (1997). [Prolonged remission of chronic hepatitis C despite corticoid and immunosuppressive treatment].. PubMed. 21(8-9). 635–635. 1 indexed citations
14.
Texereau, Patrick, et al.. (1989). [Epidemiology of intestinal functional disorders].. PubMed. 18(26). 1281–4. 3 indexed citations
15.
Texereau, Patrick, et al.. (1987). [A case of acute agranulocytosis in a patient treated with ranitidine].. PubMed. 11(11). 829–30. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dong Ma Breakdown of academic impact, for papers by Catherine Leger Breakdown of academic impact, for papers by Pierre-Guillaume Poureau Breakdown of academic impact, for papers by Thomas Göhler Breakdown of academic impact, for papers by Juan José Reina Breakdown of academic impact, for papers by Philip He Breakdown of academic impact, for papers by Hendrik Kroening Breakdown of academic impact, for papers by Oxana Crysler Breakdown of academic impact, for papers by M. Frueh Breakdown of academic impact, for papers by G. Pancera
Rankless by CCL
2026